www.technavio.comenquiry@technavio.com

Global Melanoma Therapeutics Market 2015-2019

Covered in this Report• This report covers the present scenario and the growth

prospects of the Global Melanoma Therapeutics market for the period 2015-2019.

• To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of melanoma that are available in the market.

• The market is divided into four segments: CM, OM, MM, and Others.

• Technavio's report, Global Melanoma Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.

• The report also includes a discussion of the key vendors operating in this market.

Global Melanoma Therapeutics

Market 2015-2019

USA – CANADA – UK – CHINA – INDIA

Market Overview• According to Melanoma Research Foundation, melanoma

is usually, but not always, a cancer of the skin.

• Melanoma is defined as a cancer that occurs in melanocytes (cells that make the pigment melanin).

• Chest and back in men and legs in women are the most likely parts to be affected with melanoma.

• CM, MM, and OM are the three major categories of melanoma.

• According to the American Skin Association, the incidence of melanoma is increasing worldwide.

• Technavio's analysts forecast the Global Melanoma Therapeutics market to grow at a CAGR of 15.40 percent over the period 2014-2019.

To know more aboutGlobal Melanoma

Therapeutics Market 2015-2019,

please mail us atenquiry@technavio.com

USA – CANADA – UK – CHINA – INDIA

Key Vendors and Regions

• BMS

• Merck

• Roche

• AB Science

• Amgen

• Bayer

• Celgene

• Daiichi Sankyo

View Our Report: Global Melanoma Therapeutics Market 2015-2019

• Americas

• APAC

• EMEA

Vendors Regions

USA – CANADA – UK – CHINA – INDIA

Key Findings

• Emergence of Combination Therapies• Currently, physicians use combination therapies to more effectively treat patients with

melanoma. At stage IV of the disease, tumor cells spread from their origin to distant sites, and therefore one single therapy alone cannot be used for treatment.

• Strategic Collaborations• A commercial agreement proves to be highly beneficial because the distribution

networks of both companies can be used to commercialize the drug. As the market presents immense growth opportunities for the vendors, they form strategic alliances to increase their market share.

• Outsourcing of Drug Production • The outsourcing of the drug production process to CROs by pharmaceutical companies is

rapidly gaining pace.

• Increase in R&D • The market faces significant unmet medical needs in terms of the safety and efficacy of

drugs.

USA – CANADA – UK – CHINA – INDIA

Key Questions Answered in Our Report

• What will the market size be in 2019 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?

Have a question of your own about this report?

Ask our Analysts

USA – CANADA – UK – CHINA – INDIA

• Decision makers and influencers in sales & marketing, strategy, product and R&D teams rely on research from Technavio. We have a large and growing base of happy customers worldwide. Our customers include technology suppliers, end users, consulting companies, investment firms and research institutes.

• Technavio was founded in 2003 in London. We have about 300 analysts globally. We cover more than 500 technologies across 80 countries. Traditional media such as Forbes Asia and New York Times, along with other web media portals, like to quote us.

About Technavio

Some of our clients include:ACT Global, Flextronics, Huawei Technologies Co, Infosys, Harris Corporation, Infosys, Intercad, Hidaka Precision Tools & Dies Company, Huawei Technologies Co, American Capital, Analysis Group, Netscout, NTT DoCoMo

USA – CANADA – UK – CHINA – INDIA

View Our Report

Global Melanoma Therapeutics Market 2015-2019

66 Pages | SKU: IRTNTR5573

For media enquiries,

please drop us a mail at

media@technavio.com

For more on the scope of the report, mail us at

enquiry@technavio.com

Thank You!

Mail us at: enquiry@technavio.comYou can visit us at:www.technavio.com

USA – CANADA – UK – CHINA – INDIA